Relmada Therapeutics, Inc.
NASDAQ:RLMDBiotechnology
Healthcare
$3.11 -0.97%
-$0.06 today
- Market cap
- $331.82M
- Beta
- 0.39
- P/E (TTM)
- -9.6
- EPS (TTM)
- -$0.68
52W Low $0.52High $8.00
Volume 1.71M
Average 1.24M
Price history
Relmada Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-28.01%
Period high
$7.86
Period low
$2.86
Latest
$3.11
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | Jul 29, 2026 | Jul 29, 2026 | |
| 8-K | Jul 28, 2026 | Jul 28, 2026 | |
| SC 13G | Jun 22, 2026 | Jun 22, 2026 | |
| S-8 | Jun 18, 2026 | Jun 18, 2026 | |
| SC 13G | Jun 9, 2026 | Jun 9, 2026 | |
| 8-K | May 28, 2026 | May 28, 2026 | |
| S-3ASR | May 13, 2026 | May 13, 2026 |
Competitors
Who does Relmada Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about RLMD's filings, answered from its disclosures.
What is the latest RLMD filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does RLMD have?
Intrinsic Alpha currently shows 20 recent filings for RLMD.
Continue the stock analysis
Jump to another research area for this company.